Andrew Sklawer - President and CEO at Fresh Tracks Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO
Stock Symbol
FRTX on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Sklawer since 12/22/2023

Holdings reported by Andrew Sklawer for Fresh Tracks Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 39.3K $38.9K $0.99 Oct 2, 2023 Direct
Restricted Stock Units 0 $0.91 Oct 2, 2023 Direct Common Stock

Transactions reported by Andrew Sklawer for Fresh Tracks Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.